Bio Protocol vs Mitosis — how do they compare? Bio Protocol trades at Rp441.43 (market cap Rp1,01T, Rp168,09M 24h volume), while Mitosis trades at Rp454.73 (market cap Rp81,85M, Rp73,88M 24h volume). The key difference: Bio Protocol is far larger — about 12339.6× Mitosis's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Mitosis for 20 Days on average.
| BIO | MITO | |
|---|---|---|
Market Cap | Rp1,01T | Rp81,85M |
Volume (24h) | Rp168,09M | Rp73,88M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 18 Days | 20 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →